Game On: Topokine Initiates Late-Stage Trial of XAF5 Ointment for Reining in Undereye Bags
Topokine Therapeutics initiated a Phase 2b/3 trial for XAF5 Ointment for the reduction of undereye bags.
Topokine Therapeutics initiated a Phase 2b/3 trial for XAF5 Ointment for the reduction of undereye bags.
This article explores the emerging synergy between advanced skincare and laser treatments in aesthetic medicine. Highlighting Dr. Sherrif Ibrahim’s groundbreaking study, we examine how pre-treatment with medical-grade skincare can amplify results, reduce sessions, and boost patient satisfaction. Learn how this integrated approach is reshaping clinical protocols and elevating modern aesthetic practices.
GC Aesthetics has introduced Luna XT, the inaugural breast implant approved under the new European Medical Device Regulation, emphasizing enhanced safety amid increasing breast reconstruction surgeries.
Researchers from Florida Atlantic University have received a four-year, $1.2 million grant from the National Science Foundation to empower amputees to maximize their individual potential for controlling the full dexterity of artificial hands.
The study, published in Lasers in Surgery and Medicine, looked at changes in scar melanin index after fractional ablative laser treatment in patients of various Fitzpatrick skin types.
APONVIE, from Heron Therapeutics, is an injectable emulsion for IV use in adults for the prevention of postoperative nausea and vomiting.